| P2093 | author name string | Henrique Douglas M Coutinho | |
| | Gregório Fernandes Gonçalves | |
| | Vivyanne S Falcão-Silva | |
| P2860 | cites work | Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia | Q24533461 |
| | Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis | Q80784328 |
| | Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients | Q81898474 |
| | Chronic colonization with Pandoraea apista in cystic fibrosis patients determined by repetitive-element-sequence PCR. | Q24544090 |
| | Inquilinus limosus in patients with cystic fibrosis, Germany | Q24620282 |
| | Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006 | Q24652423 |
| | Cystic fibrosis | Q28212180 |
| | Lung infections associated with cystic fibrosis | Q30080000 |
| | Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. | Q30590113 |
| | Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov | Q30695296 |
| | Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. | Q30931157 |
| | Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. | Q33859051 |
| | Antimicrobial peptide therapeutics for cystic fibrosis | Q33883742 |
| | Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. | Q33962895 |
| | Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy. | Q33982886 |
| | Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype | Q34001834 |
| | Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis. | Q34041641 |
| | Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. | Q34098657 |
| | Cystic fibrosis pathogenesis and the role of biofilms in persistent infection | Q34137953 |
| | Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation | Q34157044 |
| | Pneumonia due to Bordetella bronchiseptica in a cystic fibrosis patient: 16S rRNA sequencing for diagnosis confirmation. | Q34197176 |
| | Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients | Q34266590 |
| | Mycobacterium abscessus and children with cystic fibrosis | Q34554979 |
| | Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis | Q34610992 |
| | Persistent and aggressive bacteria in the lungs of cystic fibrosis children. | Q34628960 |
| | Polyamines increase antibiotic susceptibility in Pseudomonas aeruginosa | Q34648561 |
| | Effect of Burkholderia cepacia infection in the clinical course of patients with cystic fibrosis: a pilot study in a Sydney clinic | Q34770005 |
| | Dynamics of bacterial colonisation in the respiratory tract of patients with cystic fibrosis | Q35150316 |
| | Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis | Q35213050 |
| | Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia | Q35532451 |
| | Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis | Q35535652 |
| | Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents | Q35536173 |
| | Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. | Q35536357 |
| | Infection control in cystic fibrosis | Q35545544 |
| | Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis | Q35557791 |
| | New concepts of the pathogenesis of cystic fibrosis lung disease | Q35635720 |
| | ??? | Q28280978 |
| | Isolation of infectious cystic fibrosis patients: results of a systematic review | Q36112367 |
| | Diagnostic value of serological tests against Pseudomonas aeruginosa in a large cystic fibrosis population | Q36184109 |
| | Cystic fibrosis patient with Burkholderia pseudomallei infection acquired in Brazil | Q36314557 |
| | Update in cystic fibrosis 2005 | Q36457176 |
| | Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients | Q36528781 |
| | Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center | Q36669829 |
| | Burkholderia cepacia complex: virulence characteristics, importance and relationship with cystic fibrosis. | Q36870525 |
| | Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis | Q37125716 |
| | Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains | Q37421041 |
| | Multilayer polyelectrolyte films functionalized by insertion of defensin: a new approach to protection of implants from bacterial colonization. | Q37568405 |
| | Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection. | Q39654786 |
| | Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center. | Q39665032 |
| | Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients | Q39697563 |
| | Characteristics of Staphylococcus aureus, isolated from airways of cystic fibrosis patients, and their small colony variants | Q40740123 |
| | Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center | Q42130118 |
| | Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction | Q43065927 |
| | Novel PCR-restriction fragment length polymorphism analysis for rapid typing of staphylococcal cassette chromosome mec elements | Q43186655 |
| | Bordetella bronchiseptica infection in pediatric lung transplant recipients | Q43217767 |
| | Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats | Q44499395 |
| | Persistence of Staphylococcus aureus strains among cystic fibrosis patients over extended periods of time | Q44739064 |
| | Microbiology of sputum from patients at cystic fibrosis centers in the United States | Q44982403 |
| | Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center. | Q45089011 |
| | Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis | Q45821784 |
| | Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients | Q46650323 |
| | The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis | Q46763845 |
| | Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. | Q47855663 |
| | Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance | Q49081215 |
| | Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. | Q51697432 |
| | Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. | Q51708622 |
| | Alcaligenes infection in cystic fibrosis. | Q51711085 |
| | Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism. | Q52850739 |
| | Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis. | Q53883795 |
| | Infection withBurkholderia cepaciaComplex Genomovars in Patients with Cystic Fibrosis: Virulent Transmissible Strains of Genomovar III Can ReplaceBurkholderia multivorans | Q57265587 |
| | [Microbiological study of the respiratory tract in children with cystic fibrosis] | Q71228491 |
| | Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation | Q71703068 |
| | Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis | Q73335181 |
| | Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection? | Q73445073 |
| | Molecular epidemiology of community-acquired Staphylococcus aureus in families with and without cystic fibrosis patients | Q73556569 |
| | Nontuberculous mycobacteria in patients with cystic fibrosis | Q73753006 |
| | Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis | Q74422423 |
| | Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis | Q74659905 |
| | Multilocus restriction typing: a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis | Q78051375 |
| | National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients | Q79886453 |
| | Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development? | Q80050474 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| | antibiotic | Q12187 |
| P304 | page(s) | 24 | |
| P577 | publication date | 2008-11-07 | |
| P1433 | published in | International Archive of Medicine | Q18713043 |
| P1476 | title | Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers | |
| P478 | volume | 1 | |